These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4019115)

  • 1. The pharmacokinetics and metabolism of mitoxantrone in man.
    Ehninger G; Proksch B; Heinzel G; Schiller E; Weible KH; Woodward DL
    Invest New Drugs; 1985; 3(2):109-16. PubMed ID: 4019115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Ehninger G; Proksch B; Schiller E
    J Chromatogr; 1985 Jul; 342(1):119-27. PubMed ID: 4044741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of mitoxantrone.
    Ehninger G; Proksch B; Heinzel G; Woodward DL
    Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of mitoxantrone: mode of action and pharmacokinetics.
    Alberts DS; Peng YM; Bowden GT; Dalton WS; Mackel C
    Invest New Drugs; 1985; 3(2):101-7. PubMed ID: 4040505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of mitoxantrone in cancer patients.
    Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL
    Cancer Res; 1985 Apr; 45(4):1879-84. PubMed ID: 3978648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids.
    van Belle SJ; Schoemaker TJ; Verwey SL; Paalman AC; McVie JG
    J Chromatogr; 1985 Jan; 337(1):73-80. PubMed ID: 3980659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects on the pharmacokinetics of mitoxantrone and its two major metabolites.
    Schleyer E; Kamischke A; Kaufmann CC; Unterhalt M; Hiddemann W
    Leukemia; 1994 Mar; 8(3):435-40. PubMed ID: 8127148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone metabolism in the isolated perfused rat liver.
    Ehninger G; Proksch B; Hartmann F; Gärtner HV; Wilms K
    Cancer Chemother Pharmacol; 1984; 12(1):50-2. PubMed ID: 6690075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of mitoxantrone in cancer patients.
    Savaraj N; Lu K; Manuel V; Loo TL
    Cancer Chemother Pharmacol; 1982; 8(1):113-7. PubMed ID: 7094196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone.
    Peng YM; Ormberg D; Alberts DS; Davis TP
    J Chromatogr; 1982 Dec; 233():235-47. PubMed ID: 7161336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of mitoxantrone. A review.
    Ehninger G; Schuler U; Proksch B; Zeller KP; Blanz J
    Clin Pharmacokinet; 1990 May; 18(5):365-80. PubMed ID: 2185907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies of mitoxantrone and one of its metabolites in serum and urine in patients with advanced breast cancer.
    Rentsch KM; Schwendener RA; Pestalozzi BC; Sauter C; Wunderli-Allenspach H; Hänseler E
    Eur J Clin Pharmacol; 1998 Mar; 54(1):83-9. PubMed ID: 9591936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical pharmacology of mitozantrone.
    Smyth JF; Macpherson JS; Warrington PS; Leonard RC; Wolf CR
    Cancer Chemother Pharmacol; 1986; 17(2):149-52. PubMed ID: 3719894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography.
    Proksch B; Blanz J; Zeller KP; Ehninger G
    J Chromatogr B Biomed Appl; 1994 Aug; 658(2):349-53. PubMed ID: 7820263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and quantification of mitoxantrone in human organs. A case report.
    Roboz J; Paciucci PA; Silides D; Greaves J; Holland JF
    Cancer Chemother Pharmacol; 1984; 13(1):67-8. PubMed ID: 6375887
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.
    Richard B; Launay-Iliadis MC; Iliadis A; Just-Landi S; Blaise D; Stoppa AM; Viens P; Gaspard MH; Maraninchi D; Cano JP
    Br J Cancer; 1992 Mar; 65(3):399-404. PubMed ID: 1558794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2 [(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog.
    Lu K; Savaraj N; Loo TL
    Cancer Chemother Pharmacol; 1984; 13(1):63-6. PubMed ID: 6733844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone.
    Poirier TI
    Drug Intell Clin Pharm; 1986 Feb; 20(2):97-105. PubMed ID: 3512224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione.
    Savaraj N; Lu K; Valdivieso M; Burgess M; Umsawasdi T; Benjamin RS; Loo TL
    Clin Pharmacol Ther; 1982 Mar; 31(3):312-6. PubMed ID: 7060314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.